Skip to main content
. 2022 Mar 2;37(11):2547–2557. doi: 10.1007/s00467-022-05492-7

Table 4.

Participant inclusion and exclusion criteria

Inclusion criteria
Ages 6 to 17 years (inclusive)
Estimated glomerular filtration rate of 15–59 ml/min/1.73 m2 by the updated CKiD formula [60]
Serum phosphate within age-appropriate normal ranges
Serum ferritin < 500 ng/ml and transferrin saturation < 50%
For those patients treated with nutritional vitamin D, calcitriol, iron, and/or erythropoiesis-stimulating agents, doses must be stable for at least 2 weeks prior to screening
Able to swallow tablets
Able to eat at least two meals a day
In the opinion of the investigator, willing and able to follow the study treatment regimen and comply with the site investigator’s recommendations
Exclusion criteria
Current treatment with phosphate binders
History of allergic reactions, defined as rashes or hives, to ferric citrate or iron preparations
Current intestinal malabsorption, documented in the medical record
Anticipated initiation of dialysis or kidney transplantation within 6 months
Current or planned future systemic immunosuppressive therapy
Prior solid organ transplantation
Receipt of bone marrow transplant within 2 years of screening
Current pregnancy, current lactation, or female subjects who have reached puberty, unless using highly effective contraception
Patients participating in other interventional study (observational study participation is permitted)
Poor adherence to medical treatments in the opinion of the investigator